TrialCardiovascular diabetology2024

Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.

Shinya Fujiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.